"Interleukin-3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A multilineage cell growth factor secreted by LYMPHOCYTES; EPITHELIAL CELLS; and ASTROCYTES which stimulates clonal proliferation and differentiation of various types of blood and tissue cells.
Descriptor ID |
D007377
|
MeSH Number(s) |
D12.644.276.374.410.240.400 D12.644.276.374.465.032 D12.776.395.240.400 D12.776.467.374.410.240.400 D12.776.467.374.465.032 D23.529.374.410.240.400 D23.529.374.465.169
|
Concept/Terms |
Interleukin-3- Interleukin-3
- Interleukin 3
- IL-3
- Mast-Cell Colony-Stimulating Factor
- Multipotential Colony-Stimulating Factor
- Multipotential Colony Stimulating Factor
- Erythrocyte Burst-Promoting Factor
- Erythrocyte Burst Promoting Factor
- Burst-Promoting Factor, Erythrocyte
- Burst Promoting Factor, Erythrocyte
- Colony-Stimulating Factor 2 Alpha
- Colony-Stimulating Factor, Mast-Cell
- Colony Stimulating Factor, Mast Cell
- Colony-Stimulating Factor, Multipotential
- Colony Stimulating Factor, Multipotential
- Eosinophil-Mast Cell Growth-Factor
- Eosinophil Mast Cell Growth Factor
- Hematopoietin-2
- Hematopoietin 2
- P-Cell Stimulating Factor
- P Cell Stimulating Factor
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-3".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-3".
This graph shows the total number of publications written about "Interleukin-3" by people in this website by year, and whether "Interleukin-3" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 7 | 2 | 9 |
1995 | 5 | 4 | 9 |
1996 | 2 | 3 | 5 |
1997 | 2 | 1 | 3 |
1998 | 0 | 2 | 2 |
1999 | 0 | 3 | 3 |
2000 | 2 | 0 | 2 |
2001 | 0 | 5 | 5 |
2002 | 1 | 1 | 2 |
2003 | 2 | 0 | 2 |
2005 | 1 | 1 | 2 |
2006 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2008 | 1 | 1 | 2 |
2009 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2014 | 1 | 2 | 3 |
2018 | 1 | 0 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interleukin-3" by people in Profiles.
-
Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm. Clin Lymphoma Myeloma Leuk. 2024 04; 24(4):e130-e137.
-
Translating the biology of ? common receptor-engaging cytokines into clinical medicine. J Allergy Clin Immunol. 2023 02; 151(2):324-344.
-
Interleukin-3, symptoms and cognitive deficits in first-episode drug-na?ve and chronic medicated schizophrenia. Psychiatry Res. 2018 05; 263:147-153.
-
Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia. Schizophr Res. 2016 10; 176(2-3):196-200.
-
Increased IL-3 serum levels in chronic patients with schizophrenia: Associated with psychopathology. Psychiatry Res. 2015 Sep 30; 229(1-2):225-9.
-
Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients. Blood. 2014 Jul 17; 124(3):385-92.
-
Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy. Cancer Immunol Immunother. 2014 Aug; 63(8):835-45.
-
The role of HuR in the post-transcriptional regulation of interleukin-3 in T cells. PLoS One. 2014; 9(3):e92457.
-
ON012380, a putative BCR-ABL kinase inhibitor with a unique mechanism of action in imatinib-resistant cells. Leukemia. 2010 Apr; 24(4):869-72.
-
Identification of Flightless-I as a substrate of the cytokine-independent survival kinase CISK. J Biol Chem. 2009 May 22; 284(21):14377-85.